Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.24 trillion and total revenue of $116.52 billion.
Market Cap
1.24T
Revenue
116.52B
Profits
-35.49B
PE Ratio
n/a
Profit Margin
-30.46%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 127.22B | 0.44% | 1,298,660 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 90.58B | 4.07% | 18,858,488 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 78.09B | -1.10% | 489,284 | 15.53B |
| 4 | ARGX | argenx SE | 51.20B | 0.79% | 394,789 | 5.32B |
| 5 | ONC | BeOne Medicines AG | 42.09B | 0.30% | 289,674 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 39.04B | 2.35% | 1,978,403 | - |
| 7 | RPRX | Royalty Pharma plc | 34.66B | -1.13% | 2,813,221 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.22B | 0.63% | 1,344,464 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.06B | 3.49% | 6,333,708 | 7.53M |
| 10 | INCY | Incyte Corporation | 22.96B | 0.16% | 1,190,052 | 5.82B |
| 11 | GMAB | Genmab A/S | 22.80B | 4.05% | 4,773,437 | 4.13B |
| 12 | BNTX | BioNTech SE | 22.41B | 1.71% | 1,342,645 | 3.03B |
| 13 | INSM | Insmed Incorporated | 20.81B | -1.02% | 2,723,440 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 15.53B | 0.72% | 1,934,073 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 15.10B | 2.09% | 1,268,039 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 13.90B | 0.54% | 1,899,171 | 1.66B |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 13.53B | -0.86% | 716,916 | 4.60B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.28B | 2.33% | 2,292,327 | 713.07M |
| 19 | SMMT | Summit Therapeutics Inc. | 12.45B | 6.43% | 6,151,415 | - |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.12B | 1.76% | 392,843 | 830.81M |
| 21 | TECH | Bio-Techne Corporation | 11.37B | -0.11% | 2,573,895 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.58B | -0.02% | 2,995,128 | 3.41B |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.33B | -0.59% | 263,725 | 1.28B |
| 24 | PCVX | Vaxcyte, Inc. | 10.02B | 0.09% | 2,548,907 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 9.48B | 1.16% | 207,680 | 440.48M |
| 26 | KYMR | Kymera Therapeutics, Inc. | 8.99B | 3.14% | 683,118 | 105.00M |
| 27 | IBRX | ImmunityBio, Inc. | 8.92B | -8.28% | 19,562,081 | 165.79M |
| 28 | TWST | Twist Bioscience Corporation | 8.76B | 5.29% | 1,590,350 | 431.80M |
| 29 | CYTK | Cytokinetics, Incorporated | 8.71B | 1.13% | 1,912,762 | 67.67M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.70B | 4.42% | 654,153 | 281.99M |
| 31 | CAI | Caris Life Sciences, Inc. | 8.68B | 0.49% | 2,101,391 | 989.61M |
| 32 | AXSM | Axsome Therapeutics, Inc. | 8.16B | -0.85% | 781,729 | 776.57M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.08B | 2.38% | 1,646,664 | 669.50M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 7.92B | 6.03% | 1,272,029 | - |
| 35 | ABVX | ABIVAX Société Anonyme | 7.62B | -0.73% | 1,573,332 | 5.33M |
| 36 | TGTX | TG Therapeutics, Inc. | 7.56B | -1.24% | 1,545,965 | 799.54M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.38B | 3.35% | 3,109,987 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 7.26B | 7.61% | 860,757 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.44B | 4.33% | 8,503,802 | 324.97M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.07B | 2.39% | 378,773 | 239.92M |
| 41 | BLTE | Belite Bio, Inc | 5.93B | 3.19% | 164,377 | - |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 5.93B | 0.59% | 116,959 | 290.54M |
| 43 | KOD | Kodiak Sciences Inc. | 5.73B | 6.53% | 1,047,418 | - |
| 44 | IMVT | Immunovant, Inc. | 5.70B | 3.33% | 1,374,296 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.34B | 2.62% | 417,851 | 618.07M |
| 46 | CGON | CG Oncology, Inc. | 5.31B | 0.22% | 1,215,066 | 6.23M |
| 47 | COGT | Cogent Biosciences, Inc. | 5.21B | 1.66% | 2,541,147 | - |
| 48 | PTCT | PTC Therapeutics, Inc. | 5.14B | 3.87% | 942,774 | 1.01B |
| 49 | MANE | Veradermics, Incorporated | 5.11B | 12.37% | 1,465,873 | - |
| 50 | ORKA | Oruka Therapeutics, Inc. | 4.93B | 3.55% | 816,393 | - |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.90B | 0.85% | 1,480,015 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 4.84B | 1.60% | 1,171,640 | 13.39M |
| 53 | ERAS | Erasca, Inc. | 4.76B | 1.72% | 4,263,873 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.76B | 1.79% | 1,311,809 | 591.33M |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.43B | 2.71% | 1,735,697 | - |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.17B | 3.54% | 972,522 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.12B | 1.96% | 1,421,563 | - |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 4.01B | 10.65% | 5,795,314 | 463.98M |
| 59 | TNGX | Tango Therapeutics, Inc. | 3.97B | 6.76% | 1,870,824 | 53.81M |
| 60 | ABCL | AbCellera Biologics Inc. | 3.87B | 1.10% | 3,129,245 | 66.17M |
| 61 | RLAY | Relay Therapeutics, Inc. | 3.75B | 4.98% | 1,695,410 | 10.35M |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.65B | 0.47% | 249,783 | 890.79M |
| 63 | LEGN | Legend Biotech Corporation | 3.61B | 0.92% | 1,894,444 | 1.27B |
| 64 | ACAD | Acadia Pharmaceuticals Inc. | 3.41B | 3.56% | 1,298,611 | 1.14B |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.40B | 4.75% | 1,188,665 | 7.50M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.26B | 2.92% | 765,766 | 234.13M |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.13B | 11.43% | 2,136,774 | 148.00K |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.05B | 2.10% | 682,545 | 606.33M |
| 69 | IRON | Disc Medicine, Inc. | 3.03B | 38.86% | 8,460,170 | - |
| 70 | VKTX | Viking Therapeutics, Inc. | 2.92B | -0.48% | 3,731,850 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 2.88B | 2.44% | 2,686,355 | 3.60M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.84B | 6.88% | 3,346,143 | - |
| 73 | ELVN | Enliven Therapeutics, Inc. | 2.84B | 3.70% | 1,312,162 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 2.82B | 0.09% | 3,516,681 | 117.00M |
| 75 | CELC | Celcuity Inc. | 2.79B | 0.95% | 2,750,585 | - |
| 76 | NRIX | Nurix Therapeutics, Inc. | 2.72B | 2.09% | 3,062,839 | 701.94M |
| 77 | ZLAB | Zai Lab Limited | 2.70B | 3.75% | 383,625 | 449.61M |
| 78 | MBX | MBX Biosciences, Inc. | 2.53B | 5.79% | 522,209 | - |
| 79 | ADMA | ADMA Biologics, Inc. | 2.48B | 3.65% | 2,873,626 | 512.28M |
| 80 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45B | 3.23% | 724,162 | 7.12M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.42B | 3.07% | 1,316,241 | 156.04M |
| 82 | PGEN | Precigen, Inc. | 2.38B | 4.23% | 4,139,949 | 85.72M |
| 83 | VRDN | Viridian Therapeutics, Inc. | 2.36B | 9.30% | 2,576,139 | 71.13M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.33B | 7.77% | 1,719,329 | 158.00K |
| 85 | AUPH | Aurinia Pharmaceuticals Inc. | 2.19B | -0.12% | 552,177 | 311.51M |
| 86 | HRMY | Harmony Biosciences Holdings, Inc. | 2.19B | -1.08% | 1,008,460 | 959.90M |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.16B | 4.18% | 29,944,455 | 54.86M |
| 88 | FTRE | Fortrea Holdings Inc. | 2.13B | -0.31% | 1,652,127 | 2.68B |
| 89 | SLS | SELLAS Life Sciences Group, Inc. | 2.12B | 5.11% | 5,609,701 | - |
| 90 | PHVS | Pharvaris N.V. | 2.09B | 7.32% | 917,061 | - |
| 91 | VERA | Vera Therapeutics, Inc. | 2.08B | 3.73% | 1,269,095 | - |
| 92 | AGIO | Agios Pharmaceuticals, Inc. | 2.08B | 11.43% | 1,973,617 | 98.34M |
| 93 | VCEL | Vericel Corporation | 2.07B | 0.60% | 334,095 | 306.30M |
| 94 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -0.06% | 261,983 | 6.13M |
| 95 | IMNM | Immunome, Inc. | 1.90B | 1.82% | 1,139,854 | 4.02M |
| 96 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.37% | 139,632 | 1.13B |
| 97 | SRPT | Sarepta Therapeutics, Inc. | 1.87B | 3.68% | 2,329,399 | 1.97B |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 1.85B | 3.05% | 1,119,312 | - |
| 99 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.82B | 2.95% | 1,348,537 | 208.78M |
| 100 | ZYME | Zymeworks Inc. | 1.81B | 2.04% | 2,039,871 | 37.13M |
| 101 | NVAX | Novavax, Inc. | 1.78B | -3.91% | 6,199,195 | 413.80M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 1.77B | 2.21% | 270,926 | - |
| 103 | ZBIO | Zenas BioPharma, Inc. | 1.74B | 7.53% | 696,512 | 1.00M |
| 104 | VIR | Vir Biotechnology, Inc. | 1.73B | 2.51% | 1,301,381 | 303.23M |
| 105 | XNCR | Xencor, Inc. | 1.72B | 1.49% | 2,036,621 | 104.97M |
| 106 | BHVN | Biohaven Ltd. | 1.71B | 5.29% | 1,690,877 | - |
| 107 | SEPN | Septerna, Inc. | 1.70B | 0.08% | 410,036 | 98.88M |
| 108 | TRVI | Trevi Therapeutics, Inc. | 1.70B | 0.17% | 1,597,793 | - |
| 109 | URGN | UroGen Pharma Ltd. | 1.67B | -1.19% | 1,269,300 | 188.73M |
| 110 | MAZE | Maze Therapeutics, Inc. | 1.65B | 7.88% | 1,295,199 | 20.00M |
| 111 | NTLA | Intellia Therapeutics, Inc. | 1.62B | 1.40% | 3,499,342 | 59.51M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.61B | 3.89% | 673,669 | 26.48M |
| 113 | MESO | Mesoblast Limited | 1.61B | -10.02% | 617,787 | 120.25M |
| 114 | STOK | Stoke Therapeutics, Inc. | 1.60B | 2.69% | 711,014 | 27.59M |
| 115 | NUVB | Nuvation Bio Inc. | 1.57B | 0.67% | 4,223,372 | 169.90M |
| 116 | GPCR | Structure Therapeutics Inc. | 1.57B | 4.41% | 1,311,242 | - |
| 117 | BRVE | Braveheart Bio, Inc. | 1.57B | 2.67% | 333,741 | - |
| 118 | QURE | uniQure N.V. | 1.54B | 1.93% | 1,381,324 | 18.67M |
| 119 | IMCR | Immunocore Holdings plc | 1.54B | 1.50% | 350,976 | 430.78M |
| 120 | INVA | Innoviva, Inc. | 1.52B | 1.54% | 590,499 | 440.00M |
| 121 | COAG | Hemab Therapeutics Holdings, Inc. | 1.50B | 6.72% | 254,484 | - |
| 122 | KLRA | Kailera Therapeutics, Inc. | 1.48B | 1.60% | 896,581 | - |
| 123 | RARE | Ultragenyx Pharmaceutical Inc. | 1.48B | 3.65% | 2,984,169 | 717.00M |
| 124 | ANAB | AnaptysBio, Inc. | 1.47B | 5.64% | 467,815 | 106.09M |
| 125 | ABSI | Absci Corporation | 1.47B | 3.52% | 2,760,732 | 1.56M |
| 126 | KRSA | Korsana Biosciences, Inc. | 1.43B | -3.00% | 346,087 | - |
| 127 | AAPG | Ascentage Pharma Group International | 1.39B | -0.07% | 3,827 | 94.61M |
| 128 | OCUL | Ocular Therapeutix, Inc. | 1.38B | -8.44% | 8,357,626 | 52.06M |
| 129 | RAPP | Rapport Therapeutics, Inc. | 1.37B | 3.74% | 300,233 | 20.00M |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.33B | 4.43% | 871,842 | - |
| 131 | INBX | Inhibrx Biosciences, Inc. | 1.32B | -0.18% | 156,055 | 1.30M |
| 132 | ORIC | ORIC Pharmaceuticals, Inc. | 1.32B | 3.00% | 1,184,005 | - |
| 133 | TRAX | First Tracks Biotherapeutics, Inc. | 1.30B | 5.28% | 1,434,177 | - |
| 134 | TSHA | Taysha Gene Therapies, Inc. | 1.28B | 8.84% | 5,816,966 | 5.49M |
| 135 | GHRS | GH Research PLC | 1.25B | 0.72% | 323,085 | - |
| 136 | LBRX | LB Pharmaceuticals Inc | 1.25B | 5.63% | 588,517 | - |
| 137 | NKTR | Nektar Therapeutics | 1.25B | 2.40% | 826,499 | 54.59M |
| 138 | KARD | Kardigan, Inc. | 1.21B | -0.69% | 622,071 | - |
| 139 | DMRA | Damora Therapeutics, Inc. | 1.19B | 4.50% | 293,161 | - |
| 140 | OMER | Omeros Corporation | 1.18B | 0.93% | 1,382,777 | 38.42M |
| 141 | SLN | Silence Therapeutics plc | 1.18B | 125.58% | 71,965,890 | 615.00K |
| 142 | SVRA | Savara Inc. | 1.18B | 4.04% | 1,563,950 | - |
| 143 | SNDX | Syndax Pharmaceuticals, Inc. | 1.17B | 1.47% | 2,192,127 | 252.25M |
| 144 | DRTS | Alpha Tau Medical Ltd. | 1.17B | 2.69% | 688,367 | - |
| 145 | BCAX | Bicara Therapeutics Inc. | 1.16B | 4.11% | 864,737 | - |
| 146 | NBTX | Nanobiotix S.A. | 1.07B | 0.56% | 44,335 | 13.15M |
| 147 | CTY | City Therapeutics, Inc. | 1.07B | -4.20% | 299,344 | 14.34M |
| 148 | VOR | Vor Biopharma Inc. | 1.07B | 0.11% | 724,811 | - |
| 149 | VSTM | Verastem, Inc. | 1.05B | -0.35% | 3,398,167 | 87.53M |
| 150 | REPL | Replimune Group, Inc. | 1.04B | 1.75% | 1,539,617 | - |
| 151 | AVLN | Avalyn Pharma Inc. | 1.03B | -1.39% | 179,885 | - |
| 152 | JANX | Janux Therapeutics, Inc. | 1.02B | 1.39% | 915,058 | 24.00M |
| 153 | MNKD | MannKind Corporation | 993.56M | 1.64% | 2,457,386 | 393.63M |
| 154 | IMTX | Immatics N.V. | 963.66M | 4.75% | 966,126 | 47.65M |
| 155 | SPTX | Seaport Therapeutics, Inc. | 952.31M | -0.22% | 145,729 | - |
| 156 | LTGO | Latigo Biotherapeutics, Inc. | 948.08M | 2.14% | 283,831 | - |
| 157 | GLUE | Monte Rosa Therapeutics, Inc. | 909.44M | 9.45% | 1,925,832 | 28.73M |
| 158 | MGTX | MeiraGTx Holdings plc | 907.61M | 1.83% | 759,482 | 397.50M |
| 159 | CGEM | Cullinan Therapeutics, Inc. | 899.68M | 8.12% | 862,337 | - |
| 160 | ANRO | Alto Neuroscience, Inc. | 895.50M | 4.01% | 681,860 | - |
| 161 | AVBP | ArriVent BioPharma, Inc. | 884.58M | 7.68% | 1,013,138 | - |
| 162 | JBIO | Jade Biosciences, Inc. | 879.55M | 2.67% | 826,789 | - |
| 163 | RIGL | Rigel Pharmaceuticals, Inc. | 872.72M | 1.63% | 318,413 | 276.79M |
| 164 | SLBT | SL Science Holding Limited | 872.51M | - | 12,683 | 3.27M |
| 165 | ODTX | Odyssey Therapeutics, Inc. | 867.32M | 5.42% | 300,336 | 99.00K |
| 166 | AKTS | Aktis Oncology, Inc. | 840.41M | 0.46% | 353,421 | 10.06M |
| 167 | ABUS | Arbutus Biopharma Corporation | 836.90M | 0.24% | 1,959,257 | 181.72M |
| 168 | KURA | Kura Oncology, Inc. | 832.67M | 3.08% | 2,158,291 | 77.23M |
| 169 | MLTX | MoonLake Immunotherapeutics | 829.79M | 2.09% | 911,118 | - |
| 170 | SGP | SpyGlass Pharma, Inc. | 822.82M | 2.50% | 69,780 | - |
| 171 | ALMS | Alumis Inc. | 820.62M | 3.59% | 1,483,616 | 7.40M |
| 172 | CRVS | Corvus Pharmaceuticals, Inc. | 811.77M | 1.37% | 814,642 | - |
| 173 | HELP | Helus Pharma Inc. | 781.01M | 1.33% | 975,254 | - |
| 174 | IAM | Iambic Therapeutics, Inc. | 774.53M | -31.37% | 2,377,903 | 18.25M |
| 175 | GERN | Geron Corporation | 770.97M | 2.56% | 4,909,349 | 204.56M |
| 176 | ARDX | Ardelyx, Inc. | 769.99M | - | 3,227,243 | 450.89M |
| 177 | ANNX | Annexon, Inc. | 760.21M | 17.60% | 6,362,378 | - |
| 178 | OBX | Obsidian Therapeutics, Inc. | 737.57M | 1.44% | 106,436 | - |
| 179 | IVA | Inventiva S.A. | 717.00M | 1.36% | 3,952,579 | 2.81M |
| 180 | APMD | Apnimed, Inc. | 690.86M | -6.56% | 264,178 | 115.12M |
| 181 | LXRX | Lexicon Pharmaceuticals, Inc. | 689.68M | 1.97% | 1,723,445 | 41.47M |
| 182 | SANA | Sana Biotechnology, Inc. | 688.53M | 1.32% | 2,625,695 | - |
| 183 | OABI | OmniAb, Inc. | 681.88M | 2.18% | 892,404 | 38.46M |
| 184 | IMMX | Immix Biopharma, Inc. | 681.46M | 3.01% | 1,302,390 | - |
| 185 | PRME | Prime Medicine, Inc. | 681.37M | 10.37% | 4,250,299 | 4.07M |
| 186 | ACHV | Achieve Life Sciences, Inc. | 679.67M | 3.53% | 823,321 | - |
| 187 | FDMT | 4D Molecular Therapeutics, Inc. | 678.95M | 1.28% | 855,676 | 92.01M |
| 188 | DNA | Ginkgo Bioworks Holdings, Inc. | 678.12M | -1.95% | 2,475,430 | 132.42M |
| 189 | ANL | Adlai Nortye Group Ltd. | 668.45M | -5.89% | 356,327 | 18.06M |
| 190 | DSGN | Design Therapeutics, Inc. | 665.87M | 3.20% | 359,186 | - |
| 191 | PHAR | Pharming Group N.V. | 657.12M | -2.67% | 13,256 | 366.48M |
| 192 | AURA | Aura Biosciences, Inc. | 652.30M | 3.11% | 556,344 | - |
| 193 | GYRE | Gyre Therapeutics, Inc. | 645.75M | 0.16% | 119,928 | 109.82M |
| 194 | MDXG | MiMedx Group, Inc. | 638.43M | -1.13% | 2,686,789 | 355.17M |
| 195 | SLDB | Solid Biosciences Inc. | 634.77M | 7.05% | 1,847,796 | - |
| 196 | ATTO | Attovia Therapeutics, Inc. | 632.73M | 0.95% | 297,535 | 1.80M |
| 197 | SGMT | Sagimet Biosciences Inc. | 628.25M | 10.47% | 1,684,863 | - |
| 198 | CADL | Candel Therapeutics, Inc. | 628.22M | 0.24% | 1,278,692 | - |
| 199 | WVE | Wave Life Sciences, Inc. | 624.64M | 1.28% | 1,867,558 | 65.37M |
| 200 | OLMA | Olema Pharmaceuticals, Inc. | 622.11M | 8.05% | 1,271,973 | - |
| 201 | AVTX | Avalo Therapeutics, Inc. | 621.57M | 2.84% | 2,221,802 | 59.00K |
| 202 | NVCT | Nuvectis Pharma, Inc. | 617.09M | 1.83% | 198,177 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 603.34M | 2.21% | 719,611 | 136.07M |
| 204 | CRMD | CorMedix Inc. | 575.23M | 1.65% | 1,472,361 | 462.25M |
| 205 | CLYM | Climb Bio, Inc. | 558.85M | -0.92% | 1,209,412 | - |
| 206 | PHAT | Phathom Pharmaceuticals, Inc. | 556.80M | 1.30% | 1,017,108 | 239.66M |
| 207 | ETRA | Electra Therapeutics, Inc. | 542.93M | -1.14% | 308,986 | - |
| 208 | STTK | Shattuck Labs, Inc. | 538.95M | -0.92% | 869,584 | 1.00M |
| 209 | DBVT | DBV Technologies S.A. | 530.92M | -0.55% | 269,540 | 5.04M |
| 210 | CBIO | Crescent Biopharma, Inc. | 529.02M | 4.56% | 230,691 | 11.88M |
| 211 | PBYI | Puma Biotechnology, Inc. | 527.04M | 3.87% | 459,836 | 231.24M |
| 212 | DRUG | Bright Minds Biosciences Inc. | 521.97M | 4.91% | 156,303 | - |
| 213 | VALN | Valneva SE | 515.28M | -1.78% | 9,143 | 163.30M |
| 214 | ACRS | Aclaris Therapeutics, Inc. | 512.25M | 6.10% | 1,747,401 | 8.22M |
| 215 | ENTX | Entera Bio Ltd. | 511.33M | 9.70% | 953,135 | 42.00K |
| 216 | CTMX | CytomX Therapeutics, Inc. | 509.88M | 2.63% | 2,046,848 | 18.30M |
| 217 | FTH | Faeth Therapeutics, Inc. | 502.34M | 3.40% | 350,610 | - |
| 218 | NGNE | Neurogene Inc. | 483.68M | 3.96% | 240,155 | 925.00K |
| 219 | MNPR | Monopar Therapeutics Inc. | 479.72M | 3.18% | 73,776 | - |
| 220 | ARVN | Arvinas, Inc. | 474.70M | 4.16% | 795,634 | 316.70M |
| 221 | RGNX | REGENXBIO Inc. | 471.99M | 3.17% | 1,297,965 | 174.48M |
| 222 | EPRX | Eupraxia Pharmaceuticals Inc. | 459.86M | 4.98% | 398,524 | - |
| 223 | BLSM | BlossomHill Therapeutics, Inc. | 451.98M | 2.01% | 189,366 | - |
| 224 | OCS | Oculis Holding AG | 451.88M | 0.41% | 288,241 | 1.45M |
| 225 | ALLO | Allogene Therapeutics, Inc. | 449.14M | -0.76% | 5,905,023 | 4.64M |
| 226 | MPLT | MapLight Therapeutics, Inc. | 444.61M | 3.90% | 278,655 | - |
| 227 | PRTA | Prothena Corporation plc | 435.34M | 1.56% | 361,132 | 54.53M |
| 228 | ALT | Altimmune, Inc. | 433.77M | 1.36% | 2,609,702 | 31.00K |
| 229 | YDES | YD Bio Limited | 433.49M | 3.38% | 92,518 | 1.24M |
| 230 | DMAC | DiaMedica Therapeutics Inc. | 424.40M | 3.96% | 188,583 | - |
| 231 | OVID | Ovid Therapeutics Inc. | 423.80M | 0.93% | 1,640,687 | 1.58M |
| 232 | AUTL | Autolus Therapeutics plc | 423.20M | -0.63% | 1,522,120 | 117.39M |
| 233 | PROK | ProKidney Corp. | 421.74M | 4.89% | 966,827 | 818.00K |
| 234 | SPRY | ARS Pharmaceuticals, Inc. | 420.66M | 5.22% | 1,509,041 | 116.93M |
| 235 | EIKN | Eikon Therapeutics, Inc. | 417.07M | 3.77% | 701,600 | - |
| 236 | TECX | Tectonic Therapeutic, Inc. | 413.47M | 2.42% | 202,963 | - |
| 237 | ASMB | Assembly Biosciences, Inc. | 410.78M | 0.42% | 199,155 | 74.85M |
| 238 | AGMB | AgomAb Therapeutics NV | 405.31M | -0.60% | 34,844 | - |
| 239 | TRXB | TRex Bio, Inc. | 398.45M | 5.64% | 113,273 | - |
| 240 | RZLT | Rezolute, Inc. | 388.12M | 3.35% | 1,778,337 | - |
| 241 | CAPR | Capricor Therapeutics, Inc. | 386.62M | -0.89% | 1,911,226 | 11.13M |
| 242 | EDIT | Editas Medicine, Inc. | 371.66M | 2.98% | 2,010,880 | 47.01M |
| 243 | SCTX | Scribe Therapeutics Inc. | 367.09M | -3.44% | 259,373 | 33.30M |
| 244 | ZURA | Zura Bio Limited | 365.11M | -1.80% | 4,557,136 | - |
| 245 | INDP | Indaptus Therapeutics, Inc. | 363.75M | 3.80% | 178,218 | - |
| 246 | KYTX | Kyverna Therapeutics, Inc. | 360.55M | 2.82% | 837,420 | - |
| 247 | FENC | Fennec Pharmaceuticals Inc. | 360.14M | 2.91% | 103,534 | 59.22M |
| 248 | CCCC | C4 Therapeutics, Inc. | 355.54M | 4.52% | 3,111,896 | 35.04M |
| 249 | GALT | Galectin Therapeutics Inc. | 352.47M | -3.45% | 177,265 | - |
| 250 | AVIR | Atea Pharmaceuticals, Inc. | 352.10M | 1.62% | 390,038 | - |
| 251 | PRLD | Prelude Therapeutics Incorporated | 349.15M | 3.99% | 1,587,996 | 22.42M |
| 252 | OBIO | Orchestra BioMed Holdings, Inc. | 339.59M | 3.67% | 226,543 | 31.98M |
| 253 | RLMD | Relmada Therapeutics, Inc. | 337.08M | 1.94% | 746,295 | - |
| 254 | VTVT | vTv Therapeutics Inc. | 334.72M | 1.51% | 17,912 | 36.84M |
| 255 | NAUT | Nautilus Biotechnology, Inc. | 334.68M | 27.67% | 14,959,808 | 190.00K |
| 256 | ENTA | Enanta Pharmaceuticals, Inc. | 332.32M | 2.79% | 293,409 | 65.26M |
| 257 | TTRX | Turn Therapeutics Inc. | 319.92M | 1.61% | 29,907 | - |
| 258 | IRD | Opus Genetics, Inc. | 317.81M | -0.52% | 1,525,968 | 9.86M |
| 259 | IKT | Inhibikase Therapeutics, Inc. | 299.51M | -0.30% | 1,331,839 | 1.00 |
| 260 | ARCT | Arcturus Therapeutics Holdings Inc. | 296.17M | 0.77% | 635,626 | 29.37M |
| 261 | BNTC | Benitec Biopharma Inc. | 291.62M | 3.08% | 194,119 | - |
| 262 | ARTV | Artiva Biotherapeutics, Inc. | 287.96M | 0.68% | 536,884 | 251.00K |
| 263 | FULC | Fulcrum Therapeutics, Inc. | 282.30M | 1.64% | 1,194,922 | 80.00M |
| 264 | SRZN | Surrozen, Inc. | 280.20M | 1.71% | 295,817 | 11.51M |
| 265 | CTNM | Contineum Therapeutics, Inc. | 279.90M | 5.08% | 1,796,461 | - |
| 266 | AGEN | Agenus Inc. | 278.23M | 2.32% | 734,741 | 132.69M |
| 267 | XFOR | X4 Pharmaceuticals, Inc. | 272.65M | 6.18% | 601,199 | 15.85M |
| 268 | OCGN | Ocugen, Inc. | 266.98M | 0.90% | 4,451,541 | 4.58M |
| 269 | IPSC | Century Therapeutics, Inc. | 266.18M | 7.30% | 585,234 | 109.16M |
| 270 | CUVL | Clinuvel Pharmaceuticals Limited | 264.82M | - | 5,961 | 65.05M |
| 271 | ABEO | Abeona Therapeutics Inc. | 252.18M | -0.45% | 986,039 | 25.52M |
| 272 | CABA | Cabaletta Bio, Inc. | 250.93M | 4.96% | 4,556,472 | - |
| 273 | VCRE | Vicore Pharma Holding AB (publ) | 249.86M | -1.45% | 3,573 | 412.09K |
| 274 | BCYC | Bicycle Therapeutics plc | 247.42M | 2.17% | 692,046 | 61.21M |
| 275 | VNDA | Vanda Pharmaceuticals Inc. | 247.29M | 1.49% | 671,309 | 215.72M |
| 276 | RCKT | Rocket Pharmaceuticals, Inc. | 245.90M | 2.75% | 1,850,666 | - |
| 277 | ACIU | AC Immune SA | 242.10M | 1.88% | 85,101 | 21.67M |
| 278 | LCTX | Lineage Cell Therapeutics, Inc. | 240.97M | -2.61% | 955,552 | 13.08M |
| 279 | IMRX | Immuneering Corporation | 236.79M | 1.95% | 427,039 | - |
| 280 | SABS | SAB Biotherapeutics, Inc. | 236.56M | 2.77% | 602,333 | 114.70K |
| 281 | VOGX | Vogenx, Inc. | 236.49M | 9.43% | 86,852 | - |
| 282 | PALI | Palisade Bio, Inc. | 233.52M | -4.96% | 1,837,631 | 500.00K |
| 283 | QTTB | Q32 Bio Inc. | 231.90M | 3.59% | 608,840 | 53.74M |
| 284 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 228.50M | 1.06% | 695,331 | - |
| 285 | LXEO | Lexeo Therapeutics, Inc. | 226.44M | 4.55% | 1,863,057 | - |
| 286 | GLSI | Greenwich LifeSciences, Inc. | 223.26M | 4.54% | 151,834 | - |
| 287 | FATE | Fate Therapeutics, Inc. | 222.87M | 3.91% | 1,683,405 | 6.49M |
| 288 | LRMR | Larimar Therapeutics, Inc. | 221.29M | 6.80% | 1,229,519 | - |
| 289 | KROS | Keros Therapeutics, Inc. | 219.29M | 3.75% | 210,645 | 15.01M |
| 290 | ZNTL | Zentalis Pharmaceuticals, Inc. | 217.75M | 7.98% | 2,736,598 | 26.87M |
| 291 | ALEC | Alector, Inc. | 217.73M | 5.98% | 2,366,309 | 13.86M |
| 292 | LYEL | Lyell Immunopharma, Inc. | 215.65M | 8.37% | 212,805 | 27.00K |
| 293 | IFRX | InflaRx N.V. | 213.68M | 9.85% | 2,802,672 | -11.54K |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 212.45M | 1.00% | 13,887 | 1.80M |
| 295 | MGNX | MacroGenics, Inc. | 212.12M | 2.46% | 567,504 | 175.14M |
| 296 | PYXS | Pyxis Oncology, Inc. | 210.24M | 4.76% | 1,016,861 | 11.04M |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 206.26M | -2.29% | 914,833 | 80.62M |
| 298 | CAMP | Camp4 Therapeutics Corporation | 197.05M | -0.95% | 57,666 | 4.22M |
| 299 | EVMN | Evommune, Inc. | 191.26M | 1.93% | 422,783 | 10.00M |
| 300 | PEPG | PepGen Inc. | 187.00M | 3.85% | 1,082,730 | - |
| 301 | STRO | Sutro Biopharma, Inc. | 186.62M | 2.88% | 345,146 | 45.70M |
| 302 | CGEN | Compugen Ltd. | 186.61M | 0.51% | 158,898 | 74.00M |
| 303 | YARW | Yarrow Bioscience, Inc. | 185.90M | 9.12% | 215,590 | - |
| 304 | ACOG | Alpha Cognition Inc. | 185.11M | 3.79% | 81,805 | 15.26M |
| 305 | PRQR | ProQR Therapeutics N.V. | 184.87M | - | 752,865 | 21.05M |
| 306 | RNAC | Cartesian Therapeutics, Inc. | 183.95M | -3.03% | 201,517 | 1.48M |
| 307 | SION | Sionna Therapeutics, Inc. | 181.30M | 3.08% | 1,165,506 | - |
| 308 | IVVD | Invivyd, Inc. | 179.80M | -1.39% | 4,481,444 | 58.37M |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 175.70M | 1.41% | 1,048,163 | - |
| 310 | TRDA | Entrada Therapeutics, Inc. | 173.79M | 10.30% | 586,140 | 4.69M |
| 311 | WHWK | Whitehawk Therapeutics, Inc. | 171.60M | 4.50% | 520,160 | 7.15M |
| 312 | DTIL | Precision BioSciences, Inc. | 170.85M | 7.28% | 176,468 | 45.06M |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 168.89M | -0.25% | 162,740 | 2.00M |
| 314 | NGEN | NervGen Pharma Corp. | 165.58M | -3.14% | 422,812 | - |
| 315 | MDWD | MediWound Ltd. | 163.96M | 7.17% | 190,065 | 11.86M |
| 316 | ALXO | ALX Oncology Holdings Inc. | 157.64M | 7.55% | 1,013,467 | - |
| 317 | ADAG | Adagene Inc. | 153.76M | 11.17% | 308,790 | 9.29M |
| 318 | UPB | Upstream Bio, Inc. | 153.36M | 1.45% | 1,603,638 | 3.16M |
| 319 | NBP | NovaBridge Biosciences | 150.80M | 3.17% | 661,747 | - |
| 320 | CMPX | Compass Therapeutics, Inc. | 150.37M | -2.91% | 3,118,665 | 850.00K |
| 321 | CHRS | Coherus Oncology, Inc. | 148.12M | -3.16% | 1,709,064 | 50.94M |
| 322 | CDXS | Codexis, Inc. | 144.55M | 6.45% | 1,158,507 | 77.68M |
| 323 | MENS | Jyong Biotech Ltd. | 143.27M | 4.89% | 44,819 | - |
| 324 | MOLN | Molecular Partners AG | 141.95M | 2.81% | 922 | 856.30K |
| 325 | VRXA | Veraxa Biotech AG | 141.41M | -9.91% | 119,430 | 29.54K |
| 326 | MSLE | Satellos Bioscience Inc. | 138.25M | -0.31% | 29,374 | - |
| 327 | TARA | Protara Therapeutics, Inc. | 137.69M | 0.43% | 1,178,013 | - |
| 328 | RTSN | Retension Pharmaceuticals, Inc. | 136.06M | 16.06% | 266,502 | - |
| 329 | CNTN | Canton Strategic Holdings, Inc. | 134.66M | -0.29% | 450,513 | 1.50M |
| 330 | IPHA | Innate Pharma S.A. | 133.08M | 2.10% | - | 11.21M |
| 331 | KRRO | Korro Bio, Inc. | 131.21M | 4.95% | 134,873 | 2.38M |
| 332 | RNA | Atrium Therapeutics, Inc. | 130.17M | -0.78% | 243,911 | 35.84M |
| 333 | TLSA | Tiziana Life Sciences Ltd | 129.31M | -3.81% | 332,731 | - |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 128.00M | 4.73% | 274,681 | - |
| 335 | ANTX | AN2 Therapeutics, Inc. | 127.17M | -0.30% | 330,870 | - |
| 336 | VYGR | Voyager Therapeutics, Inc. | 126.32M | 7.89% | 1,263,271 | 34.46M |
| 337 | NKTX | Nkarta, Inc. | 125.34M | -2.78% | 1,437,628 | - |
| 338 | OTLK | Outlook Therapeutics, Inc. | 120.02M | 0.98% | 2,612,845 | -1.16M |
| 339 | CUE | Cue Biopharma, Inc. | 116.81M | -3.77% | 133,109 | 37.66M |
| 340 | SPRB | Spruce Biosciences, Inc. | 116.11M | 1.89% | 57,102 | 697.00K |
| 341 | AVXL | Anavex Life Sciences Corp. | 115.87M | -4.58% | 1,873,511 | - |
| 342 | ARMP | Armata Pharmaceuticals, Inc. | 114.15M | -8.90% | 88,261 | 5.54M |
| 343 | NRXP | NRx Pharmaceuticals, Inc. | 113.78M | 1.15% | 1,085,836 | 3.39M |
| 344 | HURA | TuHURA Biosciences, Inc. | 113.43M | 1.14% | 173,408 | - |
| 345 | SEER | Seer, Inc. | 111.85M | -0.49% | 43,000 | 14.22M |
| 346 | HUMA | Humacyte, Inc. | 111.42M | -6.50% | 4,690,859 | 2.12M |
| 347 | FHTX | Foghorn Therapeutics Inc. | 111.05M | 1.08% | 440,849 | 36.74M |
| 348 | NERV | Minerva Neurosciences, Inc. | 110.77M | -1.28% | 118,295 | - |
| 349 | GNLX | Genelux Corporation | 109.79M | 1.24% | 161,469 | 8.00K |
| 350 | KZIA | Kazia Therapeutics Limited | 107.57M | 8.28% | 245,153 | 1.27M |
| 351 | TVGN | Tevogen Inc. | 106.54M | -4.24% | 1,911 | - |
| 352 | ENGN | enGene Therapeutics Inc. | 105.89M | -5.39% | 783,694 | - |
| 353 | BDTX | Black Diamond Therapeutics, Inc. | 103.99M | 5.23% | 825,543 | 70.00M |
| 354 | LENZ | LENZ Therapeutics, Inc. | 103.69M | 0.92% | 648,602 | 21.48M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 103.40M | 1.00% | 2,119,255 | 65.34K |
| 356 | VANI | Vivani Medical, Inc. | 101.03M | - | 80,816 | - |
| 357 | CBUS | Cibus, Inc. | 100.12M | 0.76% | 36,771 | 4.35M |
| 358 | PYPD | PolyPid Ltd. | 99.12M | 3.39% | 110,679 | - |
| 359 | MIST | Milestone Pharmaceuticals Inc. | 98.65M | -1.02% | 669,131 | 2.34M |
| 360 | NRXS | NeurAxis, Inc. | 98.58M | 1.95% | 194,234 | 5.32M |
| 361 | COYA | Coya Therapeutics, Inc. | 98.52M | -1.18% | 106,480 | 8.02M |
| 362 | TNXP | Tonix Pharmaceuticals Holding Corp. | 98.28M | -5.13% | 1,338,209 | 29.10M |
| 363 | UNCY | Unicycive Therapeutics, Inc. | 97.77M | 4.46% | 1,126,560 | - |
| 364 | PLYX | Polaryx Therapeutics, Inc. | 95.70M | 2.13% | 25,711 | - |
| 365 | ICCC | ImmuCell Corporation | 95.45M | -2.23% | 6,506 | 30.68M |
| 366 | IMUX | Immunic, Inc. | 95.37M | 0.29% | 319,669 | - |
| 367 | PMVP | PMV Pharmaceuticals, Inc. | 94.77M | 3.72% | 195,927 | - |
| 368 | CNXU | Conexeu Sciences Inc. | 92.80M | 7.52% | 390,301 | - |
| 369 | OKUR | OnKure Therapeutics, Inc. | 91.12M | 7.14% | 501,392 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 90.73M | -2.25% | 91,242 | - |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 90.65M | 1.51% | 456,676 | 4.88M |
| 372 | ATRA | Atara Biotherapeutics, Inc. | 89.94M | -2.40% | 12,441 | 6.19M |
| 373 | NMRA | Neumora Therapeutics, Inc. | 88.31M | -0.80% | 1,637,718 | - |
| 374 | TENX | Tenax Therapeutics, Inc. | 87.07M | 11.76% | 2,582,183 | - |
| 375 | RLYB | Rallybio Corporation | 86.83M | 0.43% | 8,081 | 646.00K |
| 376 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 86.26M | -1.33% | 735,788 | - |
| 377 | TNYA | Tenaya Therapeutics, Inc. | 84.67M | -0.81% | 3,003,146 | 1.34M |
| 378 | AARD | Aardvark Therapeutics, Inc. | 81.85M | -1.06% | 135,274 | - |
| 379 | EQ | Equillium, Inc. | 78.63M | 4.20% | 3,192,373 | 4.39M |
| 380 | CLLS | Cellectis S.A. | 77.60M | -12.40% | 224,840 | 63.82M |
| 381 | PTHS | Pelthos Therapeutics Inc. | 77.56M | 0.55% | 82,686 | 43.30M |
| 382 | TELO | Telomir Pharmaceuticals, Inc. | 76.56M | -0.95% | 28,342 | - |
| 383 | PMN | ProMIS Neurosciences, Inc. | 73.80M | 0.98% | 11,333 | - |
| 384 | OKYO | OKYO Pharma Limited | 73.47M | -0.71% | 24,113 | - |
| 385 | NTRB | Nutriband Inc. | 72.93M | -6.91% | 79,242 | 1.62M |
| 386 | ACRV | Acrivon Therapeutics, Inc. | 72.42M | 3.05% | 122,857 | - |
| 387 | MNOV | MediciNova, Inc. | 69.40M | -0.70% | 144,181 | 920.48K |
| 388 | CGTX | Cognition Therapeutics, Inc. | 69.17M | -0.33% | 575,664 | - |
| 389 | CRDF | Cardiff Oncology, Inc. | 68.90M | -1.71% | 425,577 | 508.00K |
| 390 | HRTX | Heron Therapeutics, Inc. | 68.52M | -0.03% | 1,579,926 | 151.18M |
| 391 | NTHI | NeOnc Technologies Holdings, Inc. | 67.61M | 0.74% | 112,952 | 39.99K |
| 392 | PDSB | PDS Biotechnology Corporation | 66.42M | -18.89% | 8,424,058 | - |
| 393 | CSBR | Champions Oncology, Inc. | 66.04M | 0.96% | 14,915 | 60.66M |
| 394 | SPRO | Spero Therapeutics, Inc. | 65.22M | 1.82% | 201,336 | 47.00M |
| 395 | MAIA | MAIA Biotechnology, Inc. | 65.08M | -2.73% | 799,140 | - |
| 396 | CING | Cingulate Inc. | 63.40M | - | 47,816 | - |
| 397 | ONCY | Oncolytics Biotech Inc. | 63.28M | -0.36% | 696,923 | - |
| 398 | FBIO | Fortress Biotech, Inc. | 62.37M | - | 251,529 | 68.47M |
| 399 | HYFT | MindWalk Holdings Corp. | 62.19M | 0.76% | 136,344 | 11.57M |
| 400 | XBIT | XBiotech Inc. | 60.98M | -5.66% | 384,627 | - |
| 401 | BMEA | Biomea Fusion, Inc. | 60.56M | -3.84% | 1,564,991 | - |
| 402 | VRCA | Verrica Pharmaceuticals Inc. | 59.10M | -4.31% | 79,829 | 30.32M |
| 403 | OSTX | OS Therapies Incorporated | 58.68M | -3.79% | 704,744 | - |
| 404 | CNTB | Connect Biopharma Holdings Limited | 56.66M | -0.72% | 1,004,690 | 2.95M |
| 405 | ALPS | Alps Group Inc | 56.58M | - | 40,653 | 3.74M |
| 406 | PLRX | Pliant Therapeutics, Inc. | 55.65M | -0.13% | 291,796 | - |
| 407 | XLO | Xilio Therapeutics, Inc. | 54.81M | -2.57% | 9,492 | 64.09M |
| 408 | GANX | Gain Therapeutics, Inc. | 54.55M | -0.79% | 532,110 | - |
| 409 | BOLD | Boundless Bio, Inc. | 52.54M | -0.43% | 219,721 | - |
| 410 | RNXT | RenovoRx, Inc. | 52.35M | 1.75% | 288,381 | 1.98M |
| 411 | GOSS | Gossamer Bio, Inc. | 51.56M | -3.88% | 180,832 | 53.29M |
| 412 | ATHE | Alterity Therapeutics Limited | 51.20M | -7.25% | 21,891 | 2.50M |
| 413 | HOWL | Werewolf Therapeutics, Inc. | 50.54M | 6.12% | 378,569 | 21.00M |
| 414 | ELOX | Eloxx Pharmaceuticals, Inc. | 50.46M | -4.07% | 32,438 | - |
| 415 | CRBU | Caribou Biosciences, Inc. | 49.74M | -1.26% | 3,801,170 | 10.04M |
| 416 | IBIO | iBio, Inc. | 48.88M | -0.81% | 355,593 | 100.00K |
| 417 | INKT | MiNK Therapeutics, Inc. | 48.78M | 1.59% | 14,149 | - |
| 418 | ACET | Adicet Bio, Inc. | 48.76M | -0.88% | 230,308 | - |
| 419 | APLM | Apollomics, Inc. | 48.42M | 4.49% | 5,457 | 8.84M |
| 420 | MREO | Mereo BioPharma Group plc | 48.24M | -0.30% | 530,718 | 500.00K |
| 421 | RNTX | Rein Therapeutics Inc. | 47.62M | -6.49% | 502,153 | - |
| 422 | LONA | LeonaBio, Inc. | 47.58M | -2.88% | 41,003 | - |
| 423 | CLNN | Clene Inc. | 46.76M | 6.13% | 88,488 | 197.00K |
| 424 | KLRS | Kalaris Therapeutics, Inc. | 45.47M | -4.50% | 271,522 | - |
| 425 | IMA | ImageneBio, Inc. | 45.41M | -0.99% | 6,063 | 800.00K |
| 426 | HYPD | Hyperion DeFi, Inc. | 44.44M | 0.70% | 271,106 | 1.40M |
| 427 | INMB | INmune Bio Inc. | 42.74M | -1.91% | 156,528 | 50.00K |
| 428 | SER | Serina Therapeutics, Inc. | 41.91M | -4.07% | 22,055 | 130.00K |
| 429 | ATNM | Actinium Pharmaceuticals, Inc. | 41.50M | 16.81% | 658,396 | 35.09M |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 41.13M | -0.82% | 228,224 | - |
| 431 | ANVS | Annovis Bio, Inc. | 40.90M | -3.36% | 641,347 | - |
| 432 | ELTX | Elicio Therapeutics, Inc. | 40.74M | -0.64% | 298,043 | - |
| 433 | ALDX | Aldeyra Therapeutics, Inc. | 40.12M | -5.00% | 858,330 | - |
| 434 | VERU | Veru Inc. | 39.39M | 0.43% | 88,100 | 16.89M |
| 435 | GRCE | Grace Therapeutics, Inc. | 39.34M | -1.06% | 90,430 | - |
| 436 | TIL | Instil Bio, Inc. | 39.27M | -2.03% | 147,895 | - |
| 437 | EYPT | EyePoint, Inc. | 37.93M | -85.28% | 184,371,249 | 2.79M |
| 438 | CELU | Celularity Inc. | 37.64M | -7.20% | 82,153 | 18.97M |
| 439 | EDSA | Edesa Biotech, Inc. | 37.56M | 8.17% | 24,267 | - |
| 440 | EXOZ | eXoZymes, Inc. | 37.13M | -2.20% | 8,837 | -700.00 |
| 441 | LITS | Lite Strategy, Inc. | 35.27M | 0.87% | 190,565 | - |
| 442 | IRLA | IRulya Therapeutics Inc. | 35.04M | 7.56% | 41,587 | - |
| 443 | CRVO | CervoMed Inc. | 34.93M | 3.12% | 205,394 | 331.30K |
| 444 | NNVC | NanoViricides, Inc. | 33.18M | -5.80% | 161,723 | - |
| 445 | FLNA | Filana Therapeutics, Inc. | 32.95M | -3.06% | 256,891 | - |
| 446 | GRDX | GridAI Technologies Corp. | 31.09M | 4.03% | 92,554 | - |
| 447 | MGX | Metagenomi Therapeutics, Inc. | 30.67M | 3.55% | 155,945 | 13.56M |
| 448 | ALGS | Aligos Therapeutics, Inc. | 30.22M | -0.41% | 82,008 | 31.52M |
| 449 | BCTX | BriaCell Therapeutics Corp. | 29.70M | -0.59% | 51,945 | - |
| 450 | CVM | CEL-SCI Corporation | 29.02M | -7.82% | 130,171 | - |
| 451 | RNAZ | TransCode Therapeutics, Inc. | 28.78M | - | 29,260 | - |
| 452 | BSEM | BioStem Technologies, Inc. | 28.62M | -26.32% | 404,410 | 34.59M |
| 453 | EVAX | Evaxion A/S | 27.77M | 17.67% | 462,340 | 7.49M |
| 454 | IBO | Impact BioMedical Inc. | 26.14M | 14.18% | 47,951 | 35.00K |
| 455 | NXTC | NextCure, Inc. | 25.95M | -9.13% | 67,218 | - |
| 456 | ATOS | Atossa Therapeutics, Inc. | 25.55M | -12.03% | 80,076 | - |
| 457 | IGC | IGC Pharma, Inc. | 25.02M | -1.63% | 541,213 | 1.11M |
| 458 | MCRB | Seres Therapeutics, Inc. | 24.31M | -1.63% | 23,088 | 1.88M |
| 459 | IMMP | Immutep Limited | 23.67M | -0.94% | 6,778 | 13.79M |
| 460 | ABVC | ABVC BioPharma, Inc. | 23.59M | -0.86% | 26,890 | 797.92K |
| 461 | PLRZ | Polyrizon Ltd. | 23.52M | -3.15% | 26,447 | - |
| 462 | AKTX | Akari Therapeutics, Plc | 22.60M | 20.90% | 78,177 | - |
| 463 | CNTX | Context Therapeutics Inc. | 21.90M | -2.30% | 846,263 | - |
| 464 | KYNB | Kyntra Bio, Inc. | 21.38M | 8.87% | 21,485 | 4.62M |
| 465 | BYSI | BeyondSpring Inc. | 21.09M | -8.28% | 32,369 | 1.88M |
| 466 | MRKR | Marker Therapeutics, Inc. | 20.01M | 15.38% | 579,481 | 3.55M |
| 467 | QNTM | Quantum BioPharma Ltd. | 19.49M | -2.43% | 63,589 | - |
| 468 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.12M | 2.05% | 15,671 | - |
| 469 | GUTS | Fractyl Health, Inc. | 18.31M | -10.97% | 1,126,542 | 3.00K |
| 470 | COCP | Cocrystal Pharma, Inc. | 18.23M | -7.20% | 152,284 | 330.00K |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 17.91M | 0.30% | 39,507 | 1.17M |
| 472 | ATYR | aTyr Pharma, Inc. | 16.84M | -1.32% | 2,083,183 | 190.00K |
| 473 | ESLA | Estrella Immunopharma, Inc. | 16.52M | -11.65% | 1,691,487 | - |
| 474 | ICU | SeaStar Medical Holding Corporation | 16.36M | 7.24% | 101,217 | 1.71M |
| 475 | JSPR | Jasper Therapeutics, Inc. | 15.89M | -0.52% | 391,723 | - |
| 476 | PBM | Psyence Biomedical Ltd. | 15.72M | -2.37% | 34,498 | - |
| 477 | NCEL | NewcelX Ltd. | 15.19M | 5.20% | 5,386 | - |
| 478 | RADX | Radiopharm Theranostics Limited | 15.15M | -6.50% | - | 8.90M |
| 479 | KPRX | Kiora Pharmaceuticals, Inc. | 15.14M | -0.83% | 3,074 | 20.00K |
| 480 | ACTU | Actuate Therapeutics, Inc. | 14.38M | -0.99% | 721,615 | - |
| 481 | TCRX | TScan Therapeutics, Inc. | 14.25M | -9.00% | 370,118 | 7.11M |
| 482 | ALLR | Allarity Therapeutics, Inc. | 13.89M | -2.46% | 86,913 | 345.00K |
| 483 | DARE | Daré Bioscience, Inc. | 13.89M | -2.57% | 251,678 | 1.37M |
| 484 | DYAI | Dyadic International, Inc. | 13.88M | -7.35% | 190,516 | 3.80M |
| 485 | KTTA | Pasithea Therapeutics Corp. | 13.78M | -1.83% | 18,366 | - |
| 486 | BCDA | BioCardia, Inc. | 13.59M | -2.46% | 439,729 | 3.00K |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 12.94M | -3.96% | 201,332 | - |
| 488 | HIND | Vyome Holdings, Inc. | 12.91M | -1.60% | 8,949 | 129.73K |
| 489 | LPCN | Lipocine Inc. | 12.61M | -1.92% | 322,359 | 1.57M |
| 490 | CNSY | Cerenome, Inc. | 12.52M | -2.94% | 47,365 | 4.20M |
| 491 | GTBP | GT Biopharma, Inc. | 12.07M | -4.84% | 28,564 | - |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 11.74M | -7.00% | 533,430 | 7.11M |
| 493 | AEON | AEON Biopharma, Inc. | 11.52M | -0.43% | 459,373 | - |
| 494 | PASG | Passage Bio, Inc. | 11.52M | 2.29% | 10,853 | - |
| 495 | INAB | IN8bio, Inc. | 10.75M | -1.80% | 21,692 | - |
| 496 | INTS | Intensity Therapeutics, Inc. | 10.74M | -1.79% | 7,141 | - |
| 497 | PTN | Palatin Technologies, Inc. | 10.69M | -0.50% | 56,384 | 13.19M |
| 498 | BLRX | BioLineRx Ltd. | 10.60M | -1.49% | 34,662 | 1.39M |
| 499 | CLRB | Cellectar Biosciences, Inc. | 10.59M | -1.75% | 195,252 | - |
| 500 | PPBT | Purple Biotech Ltd | 10.54M | -5.26% | 40,313 | - |